Usefulness of chorionic gonadotropin in premalignantgastric lesions
DOI:
https://doi.org/10.59471/ijhsc2024176Keywords:
Premalignant Gastric Lesions, Chorionic Gonadotropin, Stomach CancerAbstract
Introduction: knowledge of premalignant gastric lesions is crucial because only in this way can it be informed,
educated, and a surveillance plan drawn up when they are diagnosed.
Objective: to evaluate the diagnostic value of chorionic gonadotropin as a tumor marker in premalignant gastric
lesions in patients treated in the Gastroenterology service of the “Dr. Agostinho Neto” General Teaching Hospital.
Guantánamo. January 2021 – january 2023.
Method: an analytical, longitudinal, prospective study was carried out in patients treated in the gastroenterology
service.
Results: the elevated lesion predominated in 55,5 %, a greater number of patients with positive chorionic
gonadotropin in 75,6 %, with high sensitivity of 92,3 % for dysplasia, specificity and positive predictive value of
100 % and high negative predictive value between 78,4 % and 90,5 %.
Conclusions: in the investigation, there was a predominance of the endoscopic finding of an elevated lesion, a
greater number of patients with positive chorionic gonadotropin, and it turned out to be a marker with diagnostic
value to be taken into account as a tool in premalignant gastric lesions
Published
Issue
Section
License
Copyright (c) 2024 Yorvis López Santana, Yasnai Rivera Soto, Raquel Onoria Cayon Poyeaux, Lanny González López, Yamilé Calzadilla Navarro (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.